- Home
- UBX vs CALC Comparison
UBX vs CALC Comparison
Compare UBX & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBX
- CALC
- Stock Information
- Founded
- UBX 2009
- CALC 2011
- Country
- UBX United States
- CALC United States
- Employees
- UBX N/A
- CALC N/A
- Industry
- UBX Biotechnology: Pharmaceutical Preparations
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- UBX Health Care
- CALC Health Care
- Exchange
- UBX Nasdaq
- CALC Nasdaq
- Market Cap
- UBX 36.9M
- CALC 36.0M
- IPO Year
- UBX 2018
- CALC N/A
- Fundamental
- Price
- UBX $1.72
- CALC $2.07
- Analyst Decision
- UBX Strong Buy
- CALC Strong Buy
- Analyst Count
- UBX 3
- CALC 4
- Target Price
- UBX $7.33
- CALC $17.25
- AVG Volume (30 Days)
- UBX 129.4K
- CALC 33.3K
- Earning Date
- UBX 03-07-2025
- CALC 03-27-2025
- Dividend Yield
- UBX N/A
- CALC N/A
- EPS Growth
- UBX N/A
- CALC N/A
- EPS
- UBX N/A
- CALC N/A
- Revenue
- UBX N/A
- CALC N/A
- Revenue This Year
- UBX N/A
- CALC N/A
- Revenue Next Year
- UBX N/A
- CALC N/A
- P/E Ratio
- UBX N/A
- CALC N/A
- Revenue Growth
- UBX N/A
- CALC N/A
- 52 Week Low
- UBX $0.94
- CALC $1.86
- 52 Week High
- UBX $3.10
- CALC $6.27
- Technical
- Relative Strength Index (RSI)
- UBX 46.69
- CALC 34.55
- Support Level
- UBX $1.53
- CALC $2.02
- Resistance Level
- UBX $1.76
- CALC $2.35
- Average True Range (ATR)
- UBX 0.20
- CALC 0.23
- MACD
- UBX -0.02
- CALC 0.00
- Stochastic Oscillator
- UBX 34.99
- CALC 26.35
About UBX Unity Biotechnology Inc.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.